A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis

  • Mohammad Ali Mohagheghi Department of Surgical Oncology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Ramesh Omranipur Department of Surgical Oncology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Fereshteh Ensani Department of Pathology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Alireza Ghannadan Department of Pathology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Shahriar Shahriaran Department of Radiology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Farhad Samiee Radiation Oncology, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Zahra Sedighi Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Center, Tehran University of Medical Sciences, Tehran, Iran.
Keywords: Castleman’s disease, Lymphoproliferative disorders, Psoriasis, Retroperitoneal neoplasm

Abstract

We present here a 32-year-old male with advanced lately diagnosed, right sided retroperitoneal mass, which had been already treated due to progressive muco-cutaneous lesions clinically consistent with psoriasis, during recent four years. The advanced retroperitoneal mass resected surgically and reported as hyaline-vascular castleman disease with a dense focus of coarse calcification, on histopathology. Association of psoriasis and castlman disease is discussed in this case report. ####

References

Abdessayed N, Bdioui A, Ammar H, Gupta R, Mhamdi N, Guerfela M, and Mokni M. Retroperitoneal unicentric Castleman’s disease: A case report. Int J Surg Case Rep.2017; 31: 54–57.

Choh NA, Qayoom S, Shaheen F, Malik RA, Rabbani I, Gojwari T. Retroperitoneal Castlemans Disease associated with Paraneoplastic Pemphigus. Hematol Oncol Stem Cell Ther 2014;7:93-6.

DePond WD. Lymph nodes - not lymphoma, Inflammatory disorders (non-infectious), PathologyOutlines. (Accessed December 2016, 30, at http://www.pathologyoutlines.com/topic/lymphnodesangi olymphoidhyperplasiawitheosinophili.html).

Bonekamp D, Horton KM, Hruban RH, Fishman EK.Castleman Disease: The Great Mimic. Radio Graphics 2011;31:1793-807.

Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001;92:670-6.

Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, Mascaro JM Jr., et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002;147:725-32.

Would you have Castleman's disease when you have Psoriasis? (Accessed December 2016, 30, at Http://www.ehealthme.com/cs/psoriasis/castleman's disea se).

Silva JA, Mesquita Kde C, Igreja AC, Lucas IC, Freitas AF, Oliveira SM, et al. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol 2013;88:9-22.

Sears AV, Laftah Z, Al-Shakarchi I, Salisbury JR, Marcus R, Creamer D. Diagnosis of Castleman disease in a patient treated with prolonged anti-TNF biologic therapy for psoriasis and psoriatic arthritis. J Am Acad Dermatol 2015;72:1615.

Published
2017-05-16
How to Cite
1.
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z. A Case of Advanced Unicentric Retroperitoneal Castleman’s Disease, Associated With Psoriasis. Acta Med Iran. 55(4):277-279.
Section
Case Report(s)